MYOCARDIAL FIBROSIS
Clinical trials for MYOCARDIAL FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new MYOCARDIAL FIBROSIS trials appear
Sign up with your email to follow new studies for MYOCARDIAL FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smartphone coaching aims to reverse heart damage from high blood pressure
Disease control Not yet recruitingThis study tests whether a 12-month digital program with health coaching and a wearable device can reduce scarring in the heart muscle caused by high blood pressure. Researchers will enroll 200 adults aged 40-70 with early signs of heart thickening. The goal is to see if lifestyl…
Matched conditions: MYOCARDIAL FIBROSIS
Phase: NA • Sponsor: National University of Singapore • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a common heart drug reverse scarring in stiff heart failure?
Disease control Not yet recruitingThis study tests whether the drug sacubitril/valsartan can reduce scarring in the heart muscle of people with a type of heart failure called HFpEF (stiff heart). The trial will enroll 36 adults aged 50 and older with heart failure and a normal pumping function. Participants will …
Matched conditions: MYOCARDIAL FIBROSIS
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC